Blue Jet Healthcare Fair Value
Blue Jet Healthcare (BLUEJET) average fair value is ₹640.9 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹566.9 (+13.05%), fair value range ₹340.0–₹941.8. Check Blue Jet Healthcare marketcap in USD to track the company's total market size over time.
Fair Value Analysis Export
BLUEJET Fair Value vs Current Price — Valuation Summary
BLUEJET average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation.
P/B Based Valuation
Asset-Based Valuation
BLUEJET Fair Value Analysis — Data Sources & Coverage
Blue Jet Healthcare financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Blue Jet Healthcare screener.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
BLUEJET vs Healthcare Sector Peers — P/E, P/B & Market Cap
Blue Jet Healthcare P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sat Kartar Life | SATKARTAR | 12.78 | 3.19 | ₹221 |
| Jeena Sikho Lifecare | JSLL | 32.14 | 15.26 | ₹6,960 |
| SMS Lifesciences | SMSLIFE | 22.27 | 1.82 | ₹354 |
| Emcure Pharmaceuticals | EMCURE | 38.74 | 7.37 | ₹35,696 |
| Sai Life Sciences | SAILIFE | 78.41 | 11.02 | ₹26,771 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.